Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLTCL1 Activators

CLTCL1 Activators would denote a specific class of molecules that target and promote the activity of the CLTCL1 protein, which is a member of the clathrin protein family. Clathrin is a structural protein primarily known for its role in vesicle formation, particularly in the process of endocytosis where cells internalize various molecules from their surroundings. The CLTCL1 gene encodes the clathrin heavy chain-like 1 protein, which may form a component of the polyhedral clathrin triskelions that assemble into clathrin-coated pits and vesicles on the cell membrane. Activators of CLTCL1 would be expected to enhance the formation or stability of these clathrin structures, potentially affecting the efficiency of vesicle-mediated transport within cells. The identification of CLTCL1 Activators would likely involve biochemical assays designed to measure the assembly rate or stability of clathrin-coated structures, or the binding affinity of CLTCL1 to its various interaction partners within the cell.

After identifying potential CLTCL1 Activators, extensive research would be necessary to understand their mechanism of action and the effects on clathrin-mediated processes. Studies may include the analysis of the kinetics of clathrin-coated pit assembly and disassembly in the presence of these activators, using real-time imaging techniques to quantify changes in the rate of these events. Structural studies might also be employed to reveal how CLTCL1 Activators interact with the clathrin protein at the molecular level. High-resolution imaging techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy (cryo-EM) could provide insights into the binding sites and the nature of the conformational changes in CLTCL1 induced by the activators. This information could be complemented by computational modeling and molecular dynamics simulations to better understand the interaction between CLTCL1 and the activators and to predict how chemical modifications might affect their efficacy. Such detailed investigations would be critical for appreciating the role of CLTCL1 in cellular transport mechanisms and for advancing the fundamental understanding of intracellular trafficking and its regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Known to disrupt endosomal trafficking, which may lead to compensatory upregulation of proteins like CLTCL1.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

An inhibitor of the vacuolar-type H+-ATPase that can disrupt vesicular acidification and potentially enhance CLTCL1 expression.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Blocks clathrin-mediated endocytosis and may induce CLTCL1 expression as a compensatory mechanism.

Filipin III

480-49-9sc-205323
sc-205323A
500 µg
1 mg
$118.00
$148.00
26
(2)

Disrupts cholesterol-rich membrane domains, potentially affecting clathrin-mediated endocytosis and CLTCL1 levels.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Inhibits tyrosine kinases and may impact endocytic pathways, possibly altering CLTCL1 expression.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Disrupts microtubules and could affect intracellular trafficking, leading to changes in CLTCL1 expression.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Inhibits actin polymerization, which is critical for vesicle movement; this may influence CLTCL1 expression.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

A dynamin inhibitor, which could disrupt endocytosis and potentially upregulate CLTCL1 expression.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

Inhibitor of Cdc42 GTPase, which is involved in actin cytoskeleton organization that might affect CLTCL1 expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Used to inhibit lysosomal degradation, which might affect vesicle trafficking and CLTCL1 expression.